User: TahirAmin Topic: IP
Category: drugs :: everywhere
Last updated: Oct 20 2017 19:50 IST RSS 2.0
 
1 to 20 of 9,807    
Reducing Risk of Breast Cancer 20.10.2017 Latest News
Breast Cancer has the best survival rate but it's immensely essential to diagnose the cancer early in its first stage itself.
Also found in: [+]
Dr Reddy's recalls over half a million Famotidine tablet bottles in US 20.10.2017 Business Standard: Companies & Industry
Hyderabad, 20 October: Dr Reddy's Laboratories Limited has initiated a nationwide recall of over half a million bottles of Famotidine tablets, 10 mg, in the US after the drug failed impurities/degradation specifications in a routine stability testing, according to the US Food and Drug Administration(US FDA).Famotidine tablets are an OTC product used to treat and prevent ulcers in stomach and intestines. The company has initiated the voluntary recall of the product in multiple lots on October 3 and was ongoing. The action was classified as a class-lll recall, meaning the products being recalled are unlikely to cause any adverse health reaction, but violate FDA labeling or manufacturing laws."Famotidine has an out of specification result for an individual related substance observed during routine stability testing of a batch for related substances-impurity 8 at 24 month stability," the drug regulator said. These are 30-count bottles numbering 569376 across multiple lots, according to ...
Also found in: [+]
How Google's quantum computer could change the world 19.10.2017 Business Standard: Front Page Headlines
The ultra-powerful machine has the potential to disrupt everything from science and medicine to national security - assuming it works
Also found in: [+]
How UCLA is fighting proxy patent battle for expensive cancer drug in India 18.10.2017 Business Standard: Today
UCLA appears to be representing the pharma firms Pfizer, Medivation and Astellas in its battle. They aren't telling the Delhi high court about this
Also found in: [+]
Panacea Biotec rallies 13% as 22 products gets GMP compliance in Ukraine 17.10.2017 Latest News
The stock up 13% to Rs 255 after the company gets certificate of GMP compliance with manufacturing authorization for 22 medicinal products from state service of Ukraine on medicines & drugs control.
Also found in: [+]
Base Erosion and Profit Shifting guidelines stump MNCs 14.10.2017 ET: Pharma
Under BEPS, multinationals will be required to declare details of revenues earned, taxes paid, employees hired, supply chain management in every country they operate in.
Also found in: [+]
Activists challenge Pneumonia vaccine patent in Delhi High Court 14.10.2017 DNA: Mumbai
Activists have challenged the patent claims of pharma giant Pfizer on a vaccine for pneumonia in the Delhi High Court. Médecins Sans Frontières or Doctors Without Borders (India) has filed a petition to overturn the patent granted earlier this year, on August 13 by the Indian Patent Office to Pfizer. “India has dashed hopes for improved access to an affordable PCV13 when it granted a patent to Pfizer for its PCV 13 product, marketed as Prevnar13, which will expire only in 2026,” a statement issued by MSF said. In the petition, MSF argues that in August 2017, the Delhi Patent Office erroneously granted a patent to Pfizer by disregarding the evidence MSF produced indicating that the pharmaceutical giant’s claim to a patent was spurious. MSF argued that the mere addition of serotypes to the already established 7-valent vaccine did not involve a technical advancement – it was merely a tactic to preserve Pfizer’s monopoly for many more years. The decision also has broader implications, as it indicates a ...
Also found in: [+]
MSF drags govt to Delhi HC over Pfizer's pneumonia vaccine patent 14.10.2017 ET: Pharma
The Indian patent office granted Pfizer a patent for its vaccine PCV13 (13-valent pneumococcal conjugate vaccine), sold here under the brand ‘Prevenar13’ for over 10 years.
Also found in: [+]
Reducing Risk of Alzheimer's disease 12.10.2017 Latest News
Alzheimer's disease is a type of dementia; in fact it is the most common type of dementia. Around 70% cases of dementia are that of Alzheimer's disease.
Also found in: [+]
Pfizer may sell or spin off its $15-billion consumer healthcare business 10.10.2017 Business Standard: Front Page Headlines
Germany's Merck KGaA is also looking to divest its non-prescription products, including brands such as Seven Seas vitamins, which could be worth around $4.5 billion
Also found in: [+]
Data Projects That the Global Legal Cannabis Market is Expected to Grow 10.10.2017 New Kerala: World News
NEW YORK: According to a report by Grand View Research, the global medical cannabis market is projected to reach a value of USD 55.8 billion by 2025. After the elections of 2016, Washington D.C. along with 28 states have legalized cannabis for medical uses.
Also found in: [+]
Suven Life Sciences shares pare some gains after rising 10% 10.10.2017 Sify Finance
Also found in: [+]
Suven Life gets patent from New Zealand for neurological drug 10.10.2017 ET: Pharma
Suven Life said it has been granted "one product patent from New Zealand corresponding to the NCEs for the treatment of disorders associated with neuro-degenerative diseases".
Also found in: [+]
Malaysia issues compulsory license to Hepatitis C drug 9.10.2017 HBL: Home
This reignites discussion on compulsory license in India
Also found in: [+]
UNODC, INTERPOL to take part in Delhi meet on smuggling, counterfeit trade 9.10.2017 All News-IANS Stories
Various global organisations, including UNODC, INTERPOL and World Customs Organisation, will participate in the Movement Against Smuggling and Counterfeit Trade (MASCRADE) to be held here from October 12.
Also found in: [+]
Mylan surges, Teva slumps after FDA approves Copaxone copy 5.10.2017 Sify Finance
By Michael Erman and Divya Grover
Also found in: [+]
Copaxone nod a booster dose for Natco 5.10.2017 Business Standard: News Now
Settlement of patents for higher dosage can add wings
Also found in: [+]
Natco Pharma spurts 20% on USFDA nod for multiple sclerosis drug 4.10.2017 HBL: Stock Markets
Shares of Natco Pharma jumped as the company's partner, Mylan NV, has got USFDA approval to launch the much awaited generic version of multiple sclerosis drug Copaxone in the American market. The ...
Also found in: [+]
Icra sees moderate growth in pharma industry 2.10.2017 Business Standard: News Now
BS ReporterHyderabad, 2 October: Research and rating agency ICRA said Indian pharmaceutical industry was likely to register a moderate growth on the back of slowing growth from US given the relatively moderate proportion of large size drugs going off patent, increased competition leading to price erosion, generic adoption reaching saturation levels among other things.Aggregate revenues of ICRA's sample set of 21 leading players declined by 8.8 percent during the first quarter of the financial year 2017-18 vis-a-vis the prior year as against the December-March, 2017 quarter growth at 0.2 percent.The revenue growth has been subdued for the US as well as domestic market in the first quarter with the base business in US continuing to face low to mid teens price erosion, regulatory overhang for select companies and impact of GST implementation on domestic growth.ICRA stated that the negative growth in the first quarter of the current fiscal was led by trade channel destocking initiative ...
Also found in: [+]
Dr Reddy's launches key kidney ailment drug 30.9.2017 Business Standard: Companies & Industry
The DRL second Indian firm to launch generic Renvela, a limited competition drug
Also found in: [+]
1 to 20 of 9,807